Taicend, a company focused on wound healing discovery, announced a new product launching in 2026: Taicend Collagen Dressing produced from fish skin for wound healing. The product will be presented at Medica, a medical technology trade fair, in Düsseldorf, Germany—taking place on Nov. 17.
The collagen is produced through a low-temperature extraction technology combined with a formulation process that preserves the triple-helix structure of fish collagen, combining compound amino acids to help regulate inflammatory responses, activate fibroblasts and provide cellular nutrients to accelerate tissue formation, per a Nov. 7 press release.
This article is only available to registered users.
Log In to View the Full Article
Taicend, a company focused on wound healing discovery, announced a new product launching in 2026: Taicend Collagen Dressing produced from fish skin for wound healing. The product will be presented at Medica, a medical technology trade fair, in Düsseldorf, Germany—taking place on Nov. 17.
The collagen is produced through a low-temperature extraction technology combined with a formulation process that preserves the triple-helix structure of fish collagen, combining compound amino acids to help regulate inflammatory responses, activate fibroblasts and provide cellular nutrients to accelerate tissue formation, per a Nov. 7 press release.
Yielding a powder consistency, the collagen in this form allows for absorption into the wound while supporting healing and recovery. Taicend anticipates five product series using this discovery: Postoperative Care for surgical healing; Acute and chronic wound care; Pressure relief and prevention; Skin protection; and Emergency and trauma.
These categories include implications for challenging wounds such as pressure ulcers and diabetic foot ulcers, according to the release. Acellular fish skin was observed in a 2022 study as a rich source of collagen for healing the acute full‐thickness skin wounds in a rat model. After 28 days, all wounds closed across groups [1]. It concluded that fish skin as an absorbable scaffold can prevent bacterial attacks and accelerate the regeneration process since it contains rich collagen and omega‐3 fatty acids [1].
Offering the fish skin in powder form could offer clinicians a new therapeutic option for wound care. Medica 2025, where Taicend will be presenting, will begin Nov. 17 and end Nov. 20. The product is not yet available, and is set to launch in 2026, following the Medica trade fair.
References:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9705163/#:~:text=In%20this%20study%2C%20the%20Acellular%20Fish%20Skin,full%E2%80%90thickness%20skin%20wounds%20in%20a%20rat%20model.
